Skip to main content Skip to section navigation Skip to footer
Virax Biolabs Group Limited
  • Our Platforms
    • Virax Immune
    • ViraxCare
    • ViraxClear
  • Our Focus
    • T-Cell Testing
    • In Vitro Diagnostics
  • Resources
    • Investor Relations
    • Media Room
    • Events
  • About Us
    • Our Team
    • Careers
    • Contact Us
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 31, 2022 8:30am EDT

Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders

May 17, 2022 9:00am EDT

Virax Biolabs Introduces New Board of Directors, Announces Members

May 09, 2022 9:01am EDT

Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research

Apr 28, 2022 8:00am EDT

Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Virax Biolabs Group Limited
30 Broadwick Street
London
W1F 8JB
United Kingdom
Our Platforms
  • Virax Immune
  • ViraxCare
  • ViraxClear
Our Focus
  • T-Cell Testing
  • In Vitro Diagnostics
Resources
  • Media Room
  • Events
  • Investor Relations
About Us
  • Our Team
  • Careers
  • Contact Us

© All Rights Reserved, Virax Biolabs 2022 | Privacy Policy | Terms of Service